Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Audible Capital appears to be an investment firm rather than a life sciences operating company. Publicly available profiles describe it as a venture capital or angel investment organization, with activity centered primarily on sports, media, entertainment, and related technology businesses. Some databases also show at least one investment in Synaptive Medical, a medical technology company, but there is no evidence that Audible Capital itself develops therapeutics, diagnostics, or healthcare products. Based on the available information, it should not be classified as a biotech, pharma, or healthcare company. The entity name also appears in multiple geographic/company-record contexts, which creates some ambiguity around the exact legal entity.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Audible Capital.